Glaucoma screening with AI for diabetes patients
Part of Eyes & vision clinical trials.
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older
- You have diabetes (type 1 or type 2)
- You can have a photo taken of the back of your eye with a special camera
- You are willing to sign a consent form agreeing to join the study
- You are already getting eye screening through the diabetic retinopathy program at Singapore General Hospital or SingHealth Polyclinics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (AI) system that looks at eye images to find early signs of glaucoma, a condition that can damage the optic nerve and lead to vision loss. The goal is to see if the AI can accurately tell apart people with glaucoma from those with healthy eyes, which could help with earlier diagnosis and treatment.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This study uses an AI-based system to check for diabetic retinopathy during regular eye exams at primary care clinics. It may help catch vision problems early if you have diabetes.
This study tests whether a computer program (artificial intelligence) can use your eye scan images to help diagnose certain eye conditions. It might help catch problems earlier or more accurately, which could lead to better treatment.
This trial uses artificial intelligence to help diagnose eye conditions from digital eye images. If you have certain types of eye images from regular check-ups, your data might help teach the AI to recognise diseases better.
This study tests whether artificial intelligence can help detect early signs of diabetes-related eye damage before vision loss happens. You'd be screened at your regular doctor visit using a new AI tool, which could catch problems earlier than usual.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.